Page 1 of 17

IM12.{1-3,11} | Thyroid Dysfunction Foundations — SDL Guide

Learning Objectives

• Describe the epidemiology and public health burden of hypothyroidism, hyperthyroidism, and iodine deficiency disorders in India
• Explain the physiology of the hypothalamic-pituitary-thyroid axis including hormone synthesis, transport, and feedback
• Discuss the pathogenesis of Hashimoto thyroiditis and Graves disease, including the role of autoimmunity
• Describe the principle, indications, and interpretation of radioactive iodine uptake (RAIU) in thyroid diagnosis
• Describe the National Iodine Deficiency Disorders Control Programme (NIDDCP), its objectives, interventions, and monitoring indicators

INSTRUCTIONS

This module covers the foundational science of thyroid dysfunction — epidemiology, HPT axis physiology, pathogenesis of autoimmune and iodine-deficiency thyroid disease, radioiodine uptake principles, and India's public health response to iodine deficiency. It maps to NMC competencies IM12.1, IM12.2, IM12.3, and IM12.11 at the Knowledge and KH levels.

References

• Harrison's Principles of Internal Medicine, 21st ed., Ch. 400 — Disorders of the Thyroid Gland (textbook)
• API Textbook of Medicine, 10th ed. — Thyroid Disorders (textbook)
• Davidson's Principles and Practice of Medicine, 24th ed. — Thyroid Disease (textbook)
• National Iodine Deficiency Disorders Control Programme, Government of India — Programme Guidelines (guideline)
• Indian Thyroid Society Guidelines for Diagnosis and Management of Thyroid Disorders, 2019 (guideline)

---

Version 2.0 | NMC CBUC 2024

Epidemiology and Public Health Burden of Thyroid Disease

Thyroid disease presents a significant and often underestimated public health burden in India, shaped by both nutritional deficiencies and the rising tide of autoimmune disease. Understanding the epidemiology is not merely academic — it informs clinical suspicion, screening policy, and public health intervention, all of which the NMC expects you to apply in practice.

Hypothyroidism affects approximately 2–3% of the general population globally, with prevalence rising steeply in women (particularly after the fourth decade) and in populations with iodine deficiency or autoimmune predisposition. In India, data from the Indian Thyroid Society (ITS) and national surveys estimate that 1 in 10 Indians suffers from some form of thyroid disorder, with hypothyroidism dominating. Subclinical hypothyroidism — characterised by elevated TSH with normal free T4 — is even more prevalent, affecting up to 8–10% of women over 40. Overt hypothyroidism is more common in women (female-to-male ratio approximately 6–8:1), reflecting the predominance of autoimmune thyroiditis (Hashimoto thyroiditis) as its primary cause in iodine-sufficient populations.

Hyperthyroidism (thyrotoxicosis) affects approximately 0.5–1% of the population, with Graves disease accounting for 70–80% of cases in iodine-sufficient regions. The female preponderance is even more pronounced (8:1). Toxic multinodular goitre and toxic adenoma become relatively more important in iodine-deficient areas and in older patients. In contrast to the insidious onset of Graves disease in younger women, toxic multinodular goitre tends to affect older individuals and presents with a more gradual clinical course.

Iodine deficiency disorders (IDD) represent a unique dimension of Indian thyroid epidemiology. Iodine is not uniformly distributed in soil and water, and in mountainous, sub-Himalayan, and inland regions, the natural dietary supply is insufficient. Approximately 263 million Indians live in iodine-deficient areas. IDD encompasses a spectrum from simple diffuse goitre (the most visible manifestation) to hypothyroidism, cretinism (in severe congenital deficiency), impaired cognitive development in children, and increased risk of thyroid cancer (follicular carcinoma is more common in iodine-deficient populations). The most devastating consequence — endemic cretinism — results from severe iodine deficiency during pregnancy, causing irreversible intellectual disability in the offspring.

Genetic predisposition plays a meaningful role in autoimmune thyroid diseases: HLA-DR3 is associated with Graves disease; HLA-DR4 and DR5 with Hashimoto thyroiditis. Family history of autoimmune thyroid disease, type 1 diabetes, or other organ-specific autoimmune conditions significantly increases an individual's risk. However, genetic factors alone do not determine disease expression — environmental triggers (iodine excess, infections, smoking, stress, postpartum state) are required co-factors.

Iodine Deficiency Disorders and NIDDCP in India

Physiology of the Hypothalamic-Pituitary-Thyroid Axis

The hypothalamic-pituitary-thyroid (HPT) axis is the regulatory hierarchy that maintains thyroid hormone levels within a narrow physiological range. A thorough understanding of this axis — including its feedback loops, the biochemistry of thyroid hormone synthesis, and the mechanisms of peripheral action — is essential for interpreting thyroid function tests correctly and understanding how disease at each level produces distinct hormonal patterns.

Provided image

Axis structure and feedback: The hypothalamus secretes thyrotrophin-releasing hormone (TRH) from the paraventricular nucleus in a pulsatile, circadian fashion. TRH travels via the hypothalamic-portal system to the anterior pituitary, where it binds thyrotroph cells and stimulates release of thyroid-stimulating hormone (TSH). TSH acts on the thyroid gland through the TSH receptor (TSHR), a G-protein coupled receptor that activates adenylyl cyclase. The resulting cAMP cascade drives all steps of thyroid hormone synthesis: iodide uptake, organification, coupling, and hormone secretion. Circulating T4 and T3 exert negative feedback on both the hypothalamus (suppressing TRH) and the anterior pituitary (suppressing TSH). This negative feedback is the physiological basis of thyroid function testing: in primary hypothyroidism (thyroid failure), falling T4 lifts the feedback brake, and TSH rises; in primary hyperthyroidism, rising T4 intensifies feedback and suppresses TSH.

Thyroid hormone synthesis: The follicular cells of the thyroid synthesise and secrete thyroid hormones through a coordinated sequence. Iodide (I⁻) is actively transported into the follicular cell from the bloodstream by the sodium-iodide symporter (NIS), a basal membrane transporter energised by the Na⁺/K⁺-ATPase gradient. Once inside, iodide is oxidised to reactive iodine by thyroid peroxidase (TPO) (using H₂O₂ generated by DUOX2). Reactive iodine is then incorporated into tyrosine residues of thyroglobulin (Tg), a large glycoprotein stored in the follicular colloid — a process called organification. Monoiodotyrosine (MIT) and diiodotyrosine (DIT) residues are then coupled by TPO: DIT + DIT → T4 (thyroxine) and MIT + DIT → T3 (triiodothyronine). Proteolysis of stored thyroglobulin releases T4 and T3 into the bloodstream. Approximately 90% of thyroid secretion is T4; most circulating T3 arises from peripheral deiodination of T4 by deiodinase enzymes (type I deiodinase in liver and kidney; type II in brain and pituitary). The TPO enzyme and NIS are the targets of antibodies in autoimmune thyroid disease: anti-TPO antibodies (anti-thyroid peroxidase) are the marker of Hashimoto thyroiditis, and are also elevated in Graves disease.

Thyroid hormones in the circulation: T4 and T3 are almost entirely protein-bound in plasma — to thyroxine-binding globulin (TBG) (~70%), prealbumin (transthyretin), and albumin. Only the free (unbound) fraction is biologically active — Free T4 (FT4) and Free T3 (FT3). This has important clinical implications: total T4 levels change with TBG status (oestrogen excess in pregnancy or OCP use raises TBG, raising total T4 but not free T4); measuring free fractions avoids this confound.

Physiological role of T3/T4: Thyroid hormones exert their effects primarily through nuclear thyroid hormone receptors (TR-α and TR-β), which regulate gene transcription. Their actions are wide-ranging: increased basal metabolic rate (via Na⁺/K⁺-ATPase upregulation), increased cardiac rate and contractility, normal development of the brain (critical in neonatal period — congenital hypothyroidism impairs neuronal migration and myelination), linear growth (synergy with growth hormone), gut motility, and skin and hair maintenance. The broad physiological role explains the diverse clinical manifestations of both excess and deficiency.

Pathogenesis of Hypothyroidism and Hyperthyroidism

Understanding the pathogenesis of thyroid dysfunction requires appreciating how autoimmunity, iodine metabolism, and genetic predisposition converge to produce either thyroid destruction (hypothyroidism) or thyroid overstimulation (hyperthyroidism). These are not simply opposite poles of the same spectrum — they involve distinct immunological mechanisms that must be understood separately.

Hashimoto thyroiditis (autoimmune hypothyroidism) is the most common cause of hypothyroidism in iodine-sufficient populations worldwide and the leading cause in India outside of iodine deficiency zones. The pathogenesis centres on CD8+ cytotoxic T lymphocyte-mediated destruction of thyroid follicular cells, accompanied by a TH1-polarised CD4+ T helper response and B-cell production of thyroid-specific autoantibodies. The key autoantibodies are: anti-TPO antibodies (anti-thyroid peroxidase; present in >90% of Hashimoto cases — the most sensitive marker) and anti-thyroglobulin (anti-Tg) antibodies (less specific, present in ~60%). These antibodies contribute to complement-mediated cytotoxicity and facilitate antibody-dependent cellular cytotoxicity (ADCC), but they are also markers of autoimmune activation rather than solely pathogenic. The histological hallmark is lymphocytic infiltration with formation of germinal centres within the thyroid parenchyma, progressive follicular destruction, and eventual fibrosis — giving the gland its characteristic firm, rubbery texture. The disease evolves through phases: initially the autoimmune process may cause transient hyperthyroidism (Hashitoxicosis) as stored hormone leaks from damaged follicles, before progressive hypothyroidism supervenes. Genetic associations include HLA-DR4, DR5, and CTLA4 polymorphisms (impairing T regulatory cell function).

Graves disease (autoimmune hyperthyroidism) is a type II hypersensitivity reaction in which stimulatory TSH receptor antibodies (TRAb) — specifically thyroid-stimulating immunoglobulins (TSI) — bind to and constitutively activate the TSH receptor on follicular cells. Because TSI mimics TSH action but is not subject to normal feedback suppression, the thyroid is continuously driven to produce excess T4 and T3, independent of pituitary control. This is the key mechanistic distinction: in Graves disease, the pituitary response is entirely appropriate — it suppresses TSH to near-zero levels in response to excess T4/T3 — but the driver of hormone excess is the IgG antibody, which the pituitary cannot suppress. The result is autonomous, feedback-resistant overproduction. Clinically, TRAb drives all three features of Graves disease: (1) thyrotoxicosis (metabolic effects of excess T4/T3); (2) diffuse goitre (TSH-receptor stimulation drives gland hypertrophy); and (3) Graves ophthalmopathy (the TSH receptor is also expressed on orbital fibroblasts — TRAb activates these, causing glycosaminoglycan deposition, orbital inflammation, and proptosis). The dermopathy (pretibial myxoedema) and acropachy (finger clubbing-like periosteal change) are less common but pathognomonic. Genetic associations include HLA-DR3 and CTLA4 polymorphisms.

Iodine deficiency as a cause of goitre and hypothyroidism: In iodine-deficient regions, the thyroid cannot synthesise adequate T4/T3, so the pituitary responds by raising TSH levels. Chronically elevated TSH drives follicular cell proliferation and gland hypertrophy, producing endemic goitre — the most visible manifestation of IDD. If iodine deficiency is mild, the gland can partially compensate; if severe, frank hypothyroidism results. During pregnancy, iodine requirements increase substantially, making pregnant women particularly vulnerable — severe maternal hypothyroidism during the first trimester, when fetal thyroid is not yet functional, causes irreversible damage to fetal brain development (endemic cretinism: intellectual disability, deaf-mutism, spasticity). The correction of iodine deficiency through universal salt iodisation is one of the most cost-effective public health interventions in history. Paradoxically, very high iodine intake causes transient thyroid inhibition (Wolff-Chaikoff effect) and may precipitate hypothyroidism in susceptible individuals (those with subclinical Hashimoto thyroiditis, for example).

Autoimmune Thyroid Dysfunction: Hashimoto vs Graves